ExplORer Surgical is a Chicago‑based healthcare technology company that builds a cloud‑based “digital playbook” and real‑time collaboration platform for operating rooms, aimed primarily at medical device manufacturers and surgical teams to standardize procedures, accelerate device adoption, and enable remote case support and performance tracking[2][5].[3]
High‑Level Overview
- Mission: ExplORer’s stated mission is to put best practices in the hands of procedural teams by delivering scalable digital technologies that standardize workflows, enable remote collaboration, and improve surgical outcomes[2][8].[5]
- Investment philosophy (not applicable — company/product): ExplORer is a portfolio company rather than an investment firm; it was acquired by Global Healthcare Exchange (GHX) and now operates as a GHX company focused on product and market growth rather than making investments[5][8].
- Key sectors: Surgical workflow software, medtech enablement, and remote clinical/telementoring tools serving hospitals and medical device manufacturers across multiple therapeutic areas[2][3].
- Impact on the startup ecosystem: As a university‑spun clinical tech startup that secured institutional and venture backing and was later acquired by GHX, ExplORer is an example of successful commercialization of clinical research and demonstrates demand for OR digitization and medtech enablement platforms[3][6].
For a portfolio company profile (concise): ExplORer builds a cloud platform that acts as an on‑demand procedure playbook with checklists, analytics, real‑time video collaboration and remote case support for operating rooms, primarily serving medical device companies and surgical teams to reduce OR inefficiency, reinforce device techniques, and speed product adoption[2][3][9].[1] The company has shown growth through venture rounds and strategic customers, and was acquired by GHX to scale its commercial reach and integrate with procurement and supplier networks[3][5][8].
Origin Story
- Founding year and roots: ExplORer Surgical was founded in 2015 from technology developed in the University of Chicago Medical Center’s Department of Surgery by Jennifer Fried and Dr. Alex Langerman[2][5].
- Founders and background: Co‑founder Jennifer Fried (CEO/general manager) and Dr. Alex Langerman (surgeon and researcher) brought clinical operations, surgical ethics, and OR data recording expertise to the project, combining clinician insight with software development[2][5].
- How the idea emerged: The product began as a solution to reduce OR inefficiencies by capturing procedural knowledge and standardizing surgeon preferences into step‑by‑step guides to help teams prepare and run cases more efficiently[1][2].
- Early traction and pivots: Initial hospital adoption was limited by manual setup and data‑entry burdens, which led the company to pivot toward medical device manufacturers (who needed standardized procedure guides, training, and remote support), and the platform saw increased relevance during COVID‑19 when remote case support became essential[1][3][9].
- Exit: In 2021 ExplORer was acquired by Global Healthcare Exchange (GHX) to operate as a GHX company and scale its solutions across supplier and provider networks[5][8].
Core Differentiators
- Product differentiators: Combines *procedure playbooks*, *real‑time video collaboration/tele‑mentoring*, and *performance analytics* tailored to device adoption and training needs, rather than a single‑purpose checklist app[2][9].
- Market focus: Strong product–market fit with medical device manufacturers seeking reproducible procedural guidance and the ability to remotely support and track device use and training[3][2].
- Clinical provenance: Built from university hospital research with founders who are clinicians—this clinical origin informs workflow design and credibility with surgeons and OR staff[2][5].
- Integration with buyer ecosystem: Post‑acquisition by GHX, ExplORer gains distribution and alignment with procurement and supplier networks, helping link clinical best practices to supply chain/value‑based purchasing programs[8][5].
- Speed to value: Remote collaboration features (e.g., video case support) delivered timely value during pandemic‑related OR access restrictions, accelerating adoption among device customers[1][9].
Role in the Broader Tech Landscape
- Trend alignment: ExplORer rides the broader trends of OR digitization, tele‑proctoring/telementoring, and the medtech industry’s push for digital enablement to shorten device learning curves and demonstrate clinical value[9][8].
- Timing: The pandemic accelerated demand for remote case support and minimized in‑person rep presence, making ExplORer’s video collaboration and remote mentoring features particularly valuable[1][9].
- Market forces: Hospitals’ focus on efficiency and device companies’ need to demonstrate adoption and outcomes create demand for platforms that standardize technique and capture procedural data[2][8].
- Ecosystem influence: By enabling suppliers to remotely disseminate standardized procedural best practices, ExplORer helps reduce variation in device use and supports value‑based care initiatives that link utilization to outcomes and procurement decisions[8][2].
Quick Take & Future Outlook
- What’s next: As a GHX company, ExplORer is positioned to scale commercially through GHX’s supplier and provider relationships, expand into more therapeutic areas and international markets, and further integrate procedural data with procurement and value‑based metrics[5][8].
- Trends to watch: Continued demand for tele‑mentoring, integration of procedural analytics into value‑based contracting, and tighter links between clinical workflow platforms and supply‑chain/payor data will shape ExplORer’s opportunities[8][2].
- Potential evolution: If ExplORer deepens integrations with electronic medical records, OR devices, and GHX’s network analytics, it could move from a workflow and training tool toward being a data‑driven platform that influences purchasing and clinical best practices at scale[8][7].
Quick take: ExplORer Surgical turned a clinician‑driven solution for OR inefficiency into a medtech enablement platform that proved especially timely during COVID‑era restrictions and has scaled via acquisition by GHX to influence how device companies train, support, and measure procedure adoption across hospitals[1][3][5].
